Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP‐sensitive potassium channels

British Journal of Pharmacology

Volumn 116, Issue 5, 1995, Pages 2435-2440

  Hide, Emma J ^a   Ney, Peter ^a   Piper, Julie ^a   Thiemermann, Christoph ^a   Vane, John R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

ATP sensitive potassium channel; glibenclamide; ischaemic preconditioning; myocardial infarction; prostaglandin E0; Prostaglandin E1; protein kinase C

Indexed keywords

ADENOSINE TRIPHOSPHATE; DECANOIC ACID DERIVATIVE; GLIBENCLAMIDE; POTASSIUM CHANNEL; PROSTAGLANDIN E; PROSTAGLANDIN E1; PROTEIN KINASE C; 5 HYDROXYDECANOIC ACID; 5-HYDROXYDECANOIC ACID; ANTIARRHYTHMIC AGENT; ANTIDIABETIC AGENT; DRUG DERIVATIVE; HYDROXYACID; PROSTAGLANDIN E0; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART PROTECTION; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; ANIMAL; BIOTRANSFORMATION; BLOOD PRESSURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; METABOLISM; PATHOLOGY; REPERFUSION INJURY;

ADENOSINE TRIPHOSPHATE; ALPROSTADIL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BIOTRANSFORMATION; BLOOD PRESSURE; DECANOIC ACIDS; ELECTROCARDIOGRAPHY; GLYBURIDE; HEART RATE; HYDROXY ACIDS; HYPOGLYCEMIC AGENTS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; POTASSIUM CHANNELS; RABBITS; VASODILATOR AGENTS;

EID: 0028971593     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1995.tb15092.x     Document Type: Article

References (48)

1. Role of prostacyclin in the preservation of ischaemic myocardial tissue in the perfused cat heart
2. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5‐hydroxydecanoate
3. + channel opener aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes
4. A critical look at currently used indirect indices of myocardial oxygen consumption
5. 2 may activate ATP‐sensitive potassium channels in the isolated rat heart
6. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion‐reperfusion
7. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in the rabbit
8. Prostaglandins: Their disappearance from and release into the circulation
9. Coronary microangiography in the guinea pig, rabbit and ferret
10. Cardioprotective effects of nicorandil
11. Blockade of ATP‐sensitive potassium channels exacerbates myocardial stunning in dogs
12. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated rat hearts and anaesthetized dogs
13. The anti‐ischaemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide
14. 1 receptors
15. 1 receptors in myocardial ischaemia
16. 1 in experimental myocardial infarction
17. Prostacyclin‐induced vasodilation in rabbit heart is mediated by ATP‐sensitive potassium channels
18. 2 on myocardial infarct size after coronary occlusion in conscious dogs
19. Prostacyclin: A potentially valuable agent for preserving myocardial tissue in acute myocardial ischaemia
20. Myocardial protection with preconditioning
21. Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids
22. Binding properties of circulating Evans blue in rabbits as determined by disc electrophoresis
23. Protection against infarction afforded by preconditioning is mediated by A, ‐adenosine receptors in the rabbit heart
24. Prostaglandin E receptors in cardiac sarcolemma: Identification and coupling of adenylate cyclase
25. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction
26. Specific block of the anti‐ischaemic actions of cromakalim by sodium 5‐hydroxydecanoate
27. A receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion
28. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium
29. Macroscopic identification of early myocardial infarct by alterations in dehydrogenase activity
30. + channel by 5‐hydroxydecanoate in guinea‐pig ventricular myocytes
31. +) channels
32. Pharmacologic intervention in ischaemia‐induced reperfusion injury in the skeletal muscle
33. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig
34. 1 on ST‐segment elevation and regional myocardial blood flow during experimental myocardial ischaemia in dogs
35. 2 inhibits ischaemia‐induced platelet activation and prevents myocardial damage by inhibition of catecholamine release from adrenergic nerve terminals. Evidence for cAMP as common denominator
36. The cat as an in vivo model for myocardial ischemia and infarction
37. 1 inhibition of ischaemia‐induced neutrophil activation
38. Ischaemic preconditioning reduces infarct size in swine myocardium
39. 1: Inhibition of neutrophil migration and activation
40. 1 in acute myocardial infarction
41. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion
42. 1‐selective adenosine analogue protects the heart against infarction
43. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide
44. Are ATP‐sensitive potassium channels involved in the pronounced antiarrhythmic effects of preconditioning?
45. ATP channel antagonist to attenuate preconditioning in rabbit myocardium
46. Glibenclamide‐induced inhibition of the expression of inducible nitric oxide synthase in the cultured macrophages and in the anaesthetized rat
47. Preconditioning protects ischaemic rabbit heart by protein kinase C activation